R O Cannon

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi BM-derived cell therapies for cardiovascular disease
    R O Cannon
    Cardiology Branch and Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Cytotherapy 9:305-15. 2007
  2. ncbi Noninvasive determination of spatially resolved and time-resolved tissue perfusion in humans during nitric oxide inhibition and inhalation by use of a visible-reflectance hyperspectral imaging technique
    K J Zuzak
    Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda MD 20892-0510, USA
    Circulation 104:2905-10. 2001
  3. ncbi Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery
    R O Cannon
    Cardiology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland 20892 1650, USA
    J Clin Invest 108:279-87. 2001
  4. ncbi Antioxidant effect of estrogen on cytomegalovirus-induced gene expression in coronary artery smooth muscle cells
    E Speir
    Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892 1650, USA
    Circulation 102:2990-6. 2000
  5. ncbi Competition for p300 regulates transcription by estrogen receptors and nuclear factor-kappaB in human coronary smooth muscle cells
    E Speir
    Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892 1650, USA
    Circ Res 87:1006-11. 2000
  6. ncbi Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans
    M T Gladwin
    Critical Care Medicine Department of the Warren G Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA
    Proc Natl Acad Sci U S A 97:11482-7. 2000
  7. ncbi Role of nitric oxide in cardiovascular disease: focus on the endothelium
    R O Cannon
    Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Clin Chem 44:1809-19. 1998
  8. ncbi Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation
    A A Quyyumi
    Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892 1650, USA
    J Am Coll Cardiol 30:1220-7. 1997
  9. ncbi Cardiovascular potential of BM-derived stem and progenitor cells
    R O Cannon
    Cardiovascular Branch NHLBI, NIH, Bethesda, Maryland 20892, USA
    Cytotherapy 6:602-7. 2004
  10. ncbi Effects of oestrogens and selective oestrogen receptor modulators on serum lipoproteins and vascular function
    A Blum
    National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892 1650, USA
    Curr Opin Lipidol 9:575-86. 1998

Collaborators

Detail Information

Publications12

  1. ncbi BM-derived cell therapies for cardiovascular disease
    R O Cannon
    Cardiology Branch and Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Cytotherapy 9:305-15. 2007
  2. ncbi Noninvasive determination of spatially resolved and time-resolved tissue perfusion in humans during nitric oxide inhibition and inhalation by use of a visible-reflectance hyperspectral imaging technique
    K J Zuzak
    Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda MD 20892-0510, USA
    Circulation 104:2905-10. 2001
    ..This imaging method may provide an effective approach for time-resolved noninvasive monitoring of skin hemoglobin oxygen saturation and assessment of responses to therapeutic interventions in patients with vascular disease...
  3. ncbi Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery
    R O Cannon
    Cardiology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland 20892 1650, USA
    J Clin Invest 108:279-87. 2001
    ..This effect may have application for the treatment of diseases characterized by endothelial dysfunction...
  4. ncbi Antioxidant effect of estrogen on cytomegalovirus-induced gene expression in coronary artery smooth muscle cells
    E Speir
    Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892 1650, USA
    Circulation 102:2990-6. 2000
    ..Because estrogen appears to have antioxidant properties, we wished to determine whether this hormone attenuates SMC responses to CMV infection...
  5. ncbi Competition for p300 regulates transcription by estrogen receptors and nuclear factor-kappaB in human coronary smooth muscle cells
    E Speir
    Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892 1650, USA
    Circ Res 87:1006-11. 2000
    ..These actions of 17ss-estradiol may play an important role in the cytokine-induced expression of immune and inflammatory genes implicated in atherogenesis...
  6. ncbi Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans
    M T Gladwin
    Critical Care Medicine Department of the Warren G Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA
    Proc Natl Acad Sci U S A 97:11482-7. 2000
    ....
  7. ncbi Role of nitric oxide in cardiovascular disease: focus on the endothelium
    R O Cannon
    Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Clin Chem 44:1809-19. 1998
    ..Accordingly, causal relationships between improved endothelial function and reduction in myocardial ischemia and acute coronary events can now be investigated...
  8. ncbi Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation
    A A Quyyumi
    Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892 1650, USA
    J Am Coll Cardiol 30:1220-7. 1997
    ..We hypothesized that L-arginine would improve abnormal coronary vasodilation in response to physiologic stress in patients with atherosclerosis and its risk factors by reversing coronary endothelial dysfunction...
  9. ncbi Cardiovascular potential of BM-derived stem and progenitor cells
    R O Cannon
    Cardiovascular Branch NHLBI, NIH, Bethesda, Maryland 20892, USA
    Cytotherapy 6:602-7. 2004
    ....
  10. ncbi Effects of oestrogens and selective oestrogen receptor modulators on serum lipoproteins and vascular function
    A Blum
    National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892 1650, USA
    Curr Opin Lipidol 9:575-86. 1998
    ..This review updates the current knowledge of the biological effects of oestrogen and selective oestrogen receptor modulators of potential cardiovascular importance in postmenopausal women...
  11. ncbi Raloxifene-mediated increase in matrix metalloproteinase-1 production by activated monocytes
    J A Ardans
    Immunopathology Section, National Institute of Dental and Craniofacial Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Arterioscler Thromb Vasc Biol 21:1265-8. 2001
    ..In summary, raloxifene increases the production of MMP-1 in activated monocytes; this effect may be favorable in atherosclerotic arterial wall remodeling but unfavorable for plaque stability...
  12. ncbi Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris
    E F Unger
    Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20852 1428, USA
    Am J Cardiol 85:1414-9. 2000
    ..No subject had signs suggesting systemic angiogenesis. Thus, intracoronary bFGF, at doses of 3 to 30 microg/kg, was generally well tolerated in subjects with stable angina...